These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

803 related articles for article (PubMed ID: 23641007)

  • 1. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I.
    Paneni F; Beckman JA; Creager MA; Cosentino F
    Eur Heart J; 2013 Aug; 34(31):2436-43. PubMed ID: 23641007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance, diabetes, and cardiovascular risk.
    Paneni F; Costantino S; Cosentino F
    Curr Atheroscler Rep; 2014 Jul; 16(7):419. PubMed ID: 24781596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach.
    Folli F; Corradi D; Fanti P; Davalli A; Paez A; Giaccari A; Perego C; Muscogiuri G
    Curr Diabetes Rev; 2011 Sep; 7(5):313-24. PubMed ID: 21838680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Effects and Mechanisms of Vaccarin on Vascular Endothelial Dysfunction in Diabetic Angiopathy.
    Xu F; Liu Y; Zhu X; Li S; Shi X; Li Z; Ai M; Sun J; Hou B; Cai W; Sun H; Ni L; Zhou Y; Qiu L
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atherothrombosis in patients with type 2 diabetes mellitus: an overview of pathophysiology].
    Mafrici A; Proietti R
    G Ital Cardiol (Rome); 2010 Jun; 11(6):467-77. PubMed ID: 20922872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
    Cubbon RM; Kahn MB; Wheatcroft SB
    Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes.
    Zimmerman MA; Flores SC
    J Surg Res; 2009 Jul; 155(1):173-8. PubMed ID: 18805553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress, nitric oxide, and diabetes.
    Pitocco D; Zaccardi F; Di Stasio E; Romitelli F; Santini SA; Zuppi C; Ghirlanda G
    Rev Diabet Stud; 2010; 7(1):15-25. PubMed ID: 20703435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches.
    Tousoulis D; Papageorgiou N; Androulakis E; Siasos G; Latsios G; Tentolouris K; Stefanadis C
    J Am Coll Cardiol; 2013 Aug; 62(8):667-76. PubMed ID: 23948511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes and vascular disease: basic concepts of nitric oxide physiology, endothelial dysfunction, oxidative stress and therapeutic possibilities.
    Capellini VK; Celotto AC; Baldo CF; Olivon VC; Viaro F; Rodrigues AJ; Evora PR
    Curr Vasc Pharmacol; 2010 Jul; 8(4):526-44. PubMed ID: 19485895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS?
    Meza CA; La Favor JD; Kim DH; Hickner RC
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.
    Beckman JA; Creager MA; Libby P
    JAMA; 2002 May; 287(19):2570-81. PubMed ID: 12020339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular complications in diabetes: Microparticles and microparticle associated microRNAs as active players.
    Alexandru N; Badila E; Weiss E; Cochior D; Stępień E; Georgescu A
    Biochem Biophys Res Commun; 2016 Mar; 472(1):1-10. PubMed ID: 26891868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction - a major mediator of diabetic vascular disease.
    Sena CM; Pereira AM; Seiça R
    Biochim Biophys Acta; 2013 Dec; 1832(12):2216-31. PubMed ID: 23994612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distinctive nature of atherosclerotic vascular disease in diabetes: pathophysiological and morphological insights.
    Puri R; Kataoka Y; Uno K; Nicholls SJ
    Curr Diab Rep; 2012 Jun; 12(3):280-5. PubMed ID: 22492060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular complexities underlying the vascular complications of diabetes mellitus - A comprehensive review.
    Paul S; Ali A; Katare R
    J Diabetes Complications; 2020 Aug; 34(8):107613. PubMed ID: 32505477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus.
    Endemann DH; Schiffrin EL
    Curr Hypertens Rep; 2004 Apr; 6(2):85-9. PubMed ID: 15010009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction, obesity and insulin resistance.
    Prieto D; Contreras C; Sánchez A
    Curr Vasc Pharmacol; 2014 May; 12(3):412-26. PubMed ID: 24846231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
    Rask-Madsen C; King GL
    Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition.
    Yamamoto E; Dong YF; Kataoka K; Yamashita T; Tokutomi Y; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2008 Sep; 52(3):573-80. PubMed ID: 18678790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.